NASDAQ:BNTC | Free Cash Flow | Benitec Biopharma Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2019-06-30 to 2025-09-30
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-09-30-$3.35M
2025-06-30-$8.21M$0.00-$8.21M
2024-09-30-$4.59M
2024-06-30-$3.29M$0.00-$3.29M
2023-09-30-$4.58M
2023-06-30-$4.1M$1,000.00-$4.1M
2022-09-30-$4.05M
2022-06-30-$4.86M$13,000.00-$4.87M
2021-09-30-$4.28M$0.00-$4.28M
2021-06-30-$5.16M-$141,000.00-$5.3M
2020-09-30-$2.36M$173,000.00-$2.53M
2020-06-30-$3.15M$13,000.00-$3.16M
2019-09-30-$545,000.00

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-06-30-$23.59M$18,000.00-$23.61M
2024-06-30-$19.4M$179,000.00-$19.58M
2023-06-30-$18.01M$1,000.00-$18.01M
2022-06-30-$15.9M$13,000.00-$15.91M
2021-06-30-$12.83M$221,000.00-$13.05M
2020-06-30-$7.54M$95,000.00-$7.63M
2019-06-30$4.79M$404,000.00$4.39M168.11%